Infectious Disease Clinical Trials: Navigating Innovation & Rising Complexity | Read it now: https://ow.ly/gUWf50SgXWV. Biopharma industry experts share their insights on the evolving landscape for infectious disease R&D and how to achieve future success in this roundtable summary in partnership with Cerba Research. Chijioke Bennett. MD, MPH, MBA | Trina Racine | Roxana Rustomjee, MBChB, FCPHM, MMed, PhD | Janelle Hart #InfectiousDisease #Biopharma #ClinicalResearch #CerbaResearch #HealthcareInnovation #ClinicalTrials
About us
Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.
- Website
-
https://www.citeline.com/
External link for Citeline
- Industry
- Information Services
- Company size
- 501-1,000 employees
- Headquarters
- New York, New York
- Type
- Privately Held
Locations
-
Primary
New York, New York, US
-
London, City of London, GB
Employees at Citeline
Updates
-
Citeline reposted this
Improved #clinicaltrial awareness, education, and enrollment all starts with strengthening community connections.
Communication between communities and sponsors is one of the most effective ways to create meaningful impacts on patients' lives. Explore how Legacy Health Strategies‘s new initiative, My Health, My Legacy, is fueling generations of health empowerment in communities of color. Read the article here: https://lnkd.in/eMThtty9 #Healthcare #HealthEquity #ClinicalTrials
-
-
Citeline reposted this
The FDA released the much-expected draft guidance on the Diversity Action Plans. Learn more: https://ow.ly/F6za50Sr8Ss
-
Citeline reposted this
PolTREG is one of a crop of cutting-edge firms that has made Poland a hotbed for biotech innovation, an article in In Vivo says, fully deserving the attention of U.S. investors. PolTREG plays a prominent role in the article in this widely read international magazine. Chief Executive Officer Piotr Trzonkowski in an interview talked about the exciting outlook for Treg cellular therapies, with which we one day hope to be able to prevent type-1 diabetes (T1D), and tackle a range of other autoimmune diseases. PolTREG has had a series of successes. Positive results from a long-term data study has opened the way for a pivotal trial for our lead asset PTG-007 in early-onset T1D. We are also planning to launch three new clinical studies in other indications soon. Subscribers can read the article here: https://lnkd.in/dS64K949 Citeline David Wild #biotech #biotechnology #celltherapy #cellandgenetherapy #autoimmunedisease #diabetes #type1diabetes
-
-
2023 ended with a bang as two gene therapies (Casgevy & Lyfgenia) were approved in the U.S. to treat sickle cell disease. Even more exciting, funding nearly doubled from the quarter prior with $683 million raised from 12 financings in Q4. For a full landscape check – read our latest quarterly report, made in partnership with American Society of Gene & Cell Therapy. #cgt #advancedtherapies #GeneTherapy #BiotechNews #ASGCT #CellTherapy
-
Citeline reposted this
⭐🌠 We are looking for a RWD Senior Product Marketing Manager to play a crucial role in bringing our industry-leading real-world data solutions to market! This highly visible role offers the chance to collaborate across Norstella's business units and our Real-World Data Center of Excellence to drive impactful strategies and support the delivery of the most comprehensive real-world data assets in the industry 🌠⭐ Let's chat! Norstella MMIT (Managed Markets Insight & Technology) Citeline Evaluate Ltd Panalgo The Dedham Group Elizabeth Rolla Sameer Siraj https://lnkd.in/gsPiKiFZ
Real World Data Senior Product Marketing Manager in Remote, United States
careers.norstella.com
-
Citeline reposted this
In an article on Q1 pharma earnings, MM+M included commentary from Citeline analyst Flora Mackay. She notes that Moderna’s full year net sales outlook represents a “considerable markdown” from 2023. Read it now: https://ow.ly/BQIE50SqUoL. #PharmaEarnings #BiotechNews #PharmaInsights #ModernaSales #HealthcareAnalysis
Big Pharma Q1 earnings roundup: Novo, Moderna and Regeneron report
https://www.mmm-online.com
-
Last year was pharma’s second-hottest ever in terms of new active substances (NASs) introduced to market. While the forecast for NAS launches is generally fair, there are a few clouds on the horizon in terms of a high Phase II failure rate and a small number of first-in-class drugs launched in 2023. Explore the detailed statistics on NASs in our latest infographic and delve deeper into the comprehensive report available here: https://ow.ly/eaAa50Sl3mW #PharmaTrends #DrugDevelopment #BiopharmaInsights #PharmaIndustry #PharmaStatistics
-
Citeline reposted this
Explore the forefront of pharmaceutical innovation with Norstella’s June roundup, featuring cutting-edge insights from industry trailblazers and learn about the latest news and updates from our brands. Check out the links below. 👇 Norstella announced a new strategic partnership with Atropos Health, the pioneer in translating real-world clinical data into high-quality, personalized, real-world evidence for care. Read about the benefits for Panalgo and Citeline customers: https://ow.ly/Ouay50Ss452 Citeline Regulatory's TrialScope Disclose has been the leader in helping clinical trial sponsors prepare their studies for public disclosure for over a decade. With the addition of the Core Data platform, it continues to provide cutting-edge disclosure technology to enable seamless regulatory compliance. Learn more: https://ow.ly/LZSq50Ss44Z Are you ready to look at the pharma landscape through a long-range lens? Evaluate Ltd has just released new forecasts out to 2030. Register for the World Preview Webinar 2024 Pharma’s Growth Boost: https://ow.ly/V6Jm50Ss450 Do you need a primer on market access? In this free ebook from MMIT (Managed Markets Insight & Technology) for pharma, you can learn how to understand and influence payer policies, improve coverage and communicate with HCPs. https://ow.ly/XKEN50Ss45i Understanding open and closed claims is critical. In this eBook, Panalgo's Executive Director of Solutions, Margaret (Meg) Richards, PhD, MPH, uncovers the nuances of open vs. closed claims: https://ow.ly/7I0k50Ss459 The Dedham Group stands as the premier pharmaceutical consultancy firm, renowned for its expertise in crafting, executing, and overseeing Patient Support Programs. Learn about The Dedham Group’s customized solutions that drive success: https://ow.ly/y1FG50Ss457 Follow our brands to stay up with the latest news, insights, and updates! #Pipeline2Patient #FollowNorstella
-
Less than one month remaining to enter the Global Generics & Biosimilars Awards 2024! Remember, entering the Awards is completely FREE! The Awards acknowledge the achievements made by the generics industry in delivering high quality medicines, to those around the globe, who need them most. Entries close on Monday, 22 July, 2024. Good luck with your entries! https://ow.ly/ceWG50SsXtT #GGBAwards #generics #Awards #pharmaceuticals
-